Literature DB >> 18465284

Family physicians' knowledge and screening of chronic hepatitis and liver cancer.

Jeanne M Ferrante1, Dock G Winston, Ping-Hsin Chen, Andrew N de la Torre.   

Abstract

BACKGROUND AND OBJECTIVES: Studies show that primary care providers may suboptimally diagnose, treat, or refer patients with hepatitis C virus (HCV) infection. In addition, little is known about family physicians' knowledge and practices regarding chronic hepatitis B virus (HBV) infection or monitoring for hepatocellular carcinoma (HCC).
METHODS: We used a cross-sectional mail survey of members of the New Jersey Academy of Family Physicians (n=217). Outcome measures were knowledge of risk factors, screening, counseling for chronic HCV and HBV, and screening for HCC.
RESULTS: Mean knowledge score for risk factors was 79% (HBV) and 70% (HCV). Physicians who diagnosed >or= six cases per year had higher knowledge of HBV risk factors. Physicians in practice >20 years had lower knowledge of HCV risk factors. Mean knowledge score for counseling was 77%. About 25% screened for liver cancer. Screening for HCC in patients with HBV was related to years in practice, female physicians, and group practice. Physicians in academic settings were more likely to screen patients with HCV for HCC. Forty-two percent and 51% referred patients with chronic HBV and chronic HCV, respectively, to the specialist for total management.
CONCLUSIONS: Family physicians have insufficient knowledge about screening and counseling for chronic hepatitis and hepatocellular carcinoma.

Entities:  

Mesh:

Year:  2008        PMID: 18465284

Source DB:  PubMed          Journal:  Fam Med        ISSN: 0742-3225            Impact factor:   1.756


  41 in total

1.  Duplicate hepatitis C antibody testing in New York City, 2006-2010.

Authors:  Victoria Tsai; Katherine Bornschlegel; Emily McGibbon; Stephen Arpadi
Journal:  Public Health Rep       Date:  2014 Nov-Dec       Impact factor: 2.792

2.  Evidence-based clinical guidelines for immigrants and refugees.

Authors:  Kevin Pottie; Christina Greenaway; John Feightner; Vivian Welch; Helena Swinkels; Meb Rashid; Lavanya Narasiah; Laurence J Kirmayer; Erin Ueffing; Noni E MacDonald; Ghayda Hassan; Mary McNally; Kamran Khan; Ralf Buhrmann; Sheila Dunn; Arunmozhi Dominic; Anne E McCarthy; Anita J Gagnon; Cécile Rousseau; Peter Tugwell
Journal:  CMAJ       Date:  2010-06-07       Impact factor: 8.262

3.  Hepatitis B prevention and control: Lessons from the East and the West.

Authors:  Monica C Robotin
Journal:  World J Hepatol       Date:  2011-02-27

4.  Hepatitis B learning needs assessment of family medicine trainees in Canada: results of a nationwide survey.

Authors:  Justina Joyce Sam; E Jenny Heathcote; David Kh Wong; Douglas L Wooster; Hemant Shah
Journal:  Can J Gastroenterol       Date:  2011-03       Impact factor: 3.522

Review 5.  Barriers to Disease Monitoring and Liver Cancer Surveillance Among Patients with Chronic Hepatitis B in the United States.

Authors:  Simona Ispas; Samuel So; Mehlika Toy
Journal:  J Community Health       Date:  2019-06

6.  Chronic hepatitis B management based on standard guidelines in community primary care and specialty clinics.

Authors:  Kevin C Ku; Jiayi Li; Nghi B Ha; Marina Martin; Vincent G Nguyen; Mindie H Nguyen
Journal:  Dig Dis Sci       Date:  2013-12       Impact factor: 3.199

7.  Previous exposure to HCV among persons born during 1945-1965: prevalence and predictors, United States, 1999-2008.

Authors:  Bryce D Smith; Geoff A Beckett; Anthony Yartel; Deborah Holtzman; Nita Patel; John W Ward
Journal:  Am J Public Health       Date:  2014-01-16       Impact factor: 9.308

Review 8.  Barriers to hepatitis C treatment.

Authors:  Christopher E McGowan; Michael W Fried
Journal:  Liver Int       Date:  2012-02       Impact factor: 5.828

9.  Hepatitis B management in vulnerable populations: gaps in disease monitoring and opportunities for improved care.

Authors:  Blaire E Burman; Nizar A Mukhtar; Brian C Toy; Tung T Nguyen; Alice Hm Chen; Albert Yu; Peter Berman; Hali Hammer; Daniel Chan; Charles E McCulloch; Mandana Khalili
Journal:  Dig Dis Sci       Date:  2013-09-20       Impact factor: 3.199

10.  Eastern Asian expert panel opinion: designing clinical trials of molecular targeted therapy for hepatocellular carcinoma.

Authors:  Winnie Yeo; Pei-Jer Chen; Junji Furuse; Kwang-Hyub Han; Chiun Hsu; Ho-Yeong Lim; Hanlim Moon; Shukui Qin; Ee-Min Yeoh; Sheng-Long Ye
Journal:  BMC Cancer       Date:  2010-11-10       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.